Degradation of V2 vasopressin receptor mutants

被引：0
|
作者：
Schwieger, I
Lautz, K
Wiesner, B
Hermosilla, R
机构：
[1] Charite Univ Med Berlin, Inst Pharmakol, CBF, D-14195 Berlin, Germany
[2] Forsch Inst Mol Pharmkol, D-13125 Berlin, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
81
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] A serine cluster prevents recycling of the V2 vasopressin receptor
    Innamorati, G
    Sadeghi, HM
    Tran, NT
    Birnbaumer, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) : 2222 - 2226
  • [32] Gain-of-function mutations in the V2 vasopressin receptor
    Rosenthal, Stephen M.
    Gitelman, Stephen E.
    Vargas, Gabriel A.
    Feldman, Brian J.
    HORMONE RESEARCH, 2007, 67 : 121 - 125
  • [33] RENAL V2 VASOPRESSIN RECEPTOR PROTEINS - IDENTIFICATION AND ENRICHMENT
    FAHRENHOLZ, F
    KOJRO, E
    PLAGE, G
    MULLER, M
    JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4): : 283 - 294
  • [34] Disease-causing V2 vasopressin receptor mutants induce upir in HEK293 cells
    Lautz, K
    Schwieger, I
    Brandt, U
    Wiesner, B
    Oksche, A
    Hermosilla, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 32 - 33
  • [35] Structural basis of tolvaptan binding to the vasopressin V2 receptor
    Liu, Hong-li
    Zhong, Hai-yang
    Zhang, Yi-xiao
    Xue, Hua-rui
    Zhang, Zheng-shuo
    Fu, Ke-quan
    Cao, Xu-dong
    Xiong, Xiao-chun
    Guo, Dong
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (11) : 2441 - 2449
  • [36] Analysis of vasopressin V2 receptor mutants in partial nephrogenic diabetes insipidus and their functional rescue by pharmacologic chaperones
    Makita, Noriko
    Manaka, Katsunori
    Takahashi, Kazuhiro
    Sato, Junichiro
    Oishi, Atsuro
    Yajima, Yuki
    Hashimoto, Makiko
    Sekine, Koji
    Igarashi, Takashi
    Fujita, Toshiro
    Iiri, Taroh
    ENDOCRINE JOURNAL, 2010, 57 : S623 - S624
  • [37] Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
    Morello, JP
    Salahpour, A
    Laperrière, A
    Bernier, V
    Arthus, MF
    Lonergan, M
    Petäjä-Repo, U
    Angers, S
    Morin, D
    Bichet, DG
    Bouvier, M
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07): : 887 - 895
  • [38] Rescue of the cell surface expression of functional vasopressin V2 receptor mutants in nephrogenic diabetes insipidus.
    Robben, JH
    Knoers, NV
    Deen, PMT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 32A - 32A
  • [39] Conivaptan:: A dual receptor vasopressin V1a/V2 antagonist
    Ali, Farhan
    Raufi, M. Adnan
    Washington, Barbara
    Ghali, Jalal K.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 261 - 279
  • [40] Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis
    Liu, Jun
    Sharma, Nikhil
    Zheng, Wei
    Ji, Hong
    Tam, Helen
    Wu, Xie
    Manigrasso, Michaele B.
    Sandberg, Kathryn
    Verbalis, Joseph G.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 300 (02) : F433 - F440
12345